期刊文献+

复方甘草酸苷联合强的松治疗特发性肺纤维化的疗效 被引量:1

The Therapeutic Effect of Compound Glycyrrhizin Combined with Prednisone on Idiopathic Pulmonary Fibrosis
下载PDF
导出
摘要 目的:观察复方甘草酸苷联合强的松治疗特发性肺纤维化的疗效。方法:将41例特发性肺纤维化患者随机分为对照组和治疗组。对照组口服强的松,治疗组在对照组基础上加用复方甘草酸苷,治疗3个月后比较两组血气分析、肺功能、胸部CT和总体疗效。结果:治疗组总有效率71.4%,高于对照组的50.0%(P<0.05)。治疗组在改善血气分析、肺功能方面明显优于对照组(P<0.05),两组胸部CT均有改善,但差异无统计学意义(P>0.05)。结论:复方甘草酸苷联合强的松治疗特发性肺纤维化疗效优于单用强的松。 Objective :To observe the therapeutic effect of Compound glycyrrhizin combined with prednisone on patients with idiopathic pulmonary fibrosis.Method :41 patients with idiopathic pulmonary fibrosis were randomly divided into control group and treatment group,the control group was treated with prednisone and the treatment group was treated with Compound glycyrrhizin on the basis of above treatment.Blood-gas analysis, pulmonary function tests,chest CT and total effective rates were compared between pretreatment and post treatment after three months.Result :The total effective rates were 71.4% in treatment group and 50.0% in control group ( P 0.05). The treatment group had better effect on improvement of blood- gas analysis and pulmonary function tests than the control group( P 0.05).But there was no significant difference between the two groups on chest CT.Conclusion:The therapeutic effect of Compound glycyrrhizin combined with prednisone was better than that of prednisone alone on patients with idiopathic pulmonary fibrosis.
作者 代春靖 张彬
出处 《中国医学创新》 CAS 2012年第29期6-7,共2页 Medical Innovation of China
关键词 特发性肺纤维化 复方甘草酸苷 强的松 Idiopathic pulmonary fibrosis Compound glycyrrhizin Prednisone
  • 相关文献

参考文献6

  • 1特发性肺(间质)纤维化诊断和治疗指南(草案)[J].中华结核和呼吸杂志,2002,25(7):387-389. 被引量:633
  • 2Walters D M,Cho H Y,Kleeberger S R.Oxidative stress and antioxidants in the pathogenesis of pulmonary fibrosis:a potential rote for Nrf2[J].Antioxid Redox signal,2008,10(2):321-322.
  • 3Raghu G,Collard H R,Egan J J,et al.An official ATS/ERS/JRS ALAT statement:idiopathic pulmonary fibrosis:evidence-based guidelines for diagnosis and management[J].Am J Respir crit care Med,2011,183(34):788-824.
  • 4Hyzy R,Huang S,Myers J,et al.Acute exacerbation of idiopathic pulmonary fibrosis[J].Chest,2007,132(5):1652-1658.
  • 5Hiromitsu K.Long term treatment of chronic hepatitis C with glycyrrhizin[Stronger Neo-Minophagen C(SNMC)]for preventing liver cirrhosis and hepatocellular carcinoma[J].Oncology,2002,62(Suppl1):94-100.
  • 6何燕,丁维俊,邓国忠,高天.肺纤维化模型鼠MMP/TIMP基因表达异常及复方甘草酸苷的调控机制研究[J].现代中西医结合杂志,2008,17(30):4681-4684. 被引量:3

二级参考文献10

  • 1何燕,邓国忠,高天,宋岚.复方甘草酸苷拮抗博莱霉素致大鼠肺纤维化的实验研究[J].中国药房,2006,17(7):497-499. 被引量:11
  • 2谭善忠,刘成海,张炜,陆雄,叶伟成,蔡贞贞,刘平.MMP-2/9活性与TIMP-1/2蛋白表达在大鼠肺纤维化形成中的变化特点[J].中西医结合学报,2006,4(4):402-407. 被引量:21
  • 3Taooka Y. Effects of neutrophil elastase inhibitor on bleomycin-in duced pulmonary fibrosis in mice[J]. Am J Respir Crit Care Med, 1997,156(1) :260 - 265
  • 4Manoury B. TIMP-1 is a key factor of fibrogenic response to bleomycin in mouse lung [ J ]. Int J Immunopathol Pharmacol, 2006,19(3) :471 - 487
  • 5Zhao Y & DA, Geverd. Regulation of Smad3 expression in bleomycin-induced pulmonary fibrosis: a negative feedback loop of TGF b signaling [J].Biochemical and biophysical research communications, 2002,294:319 323
  • 6Higashiyama H, Yoshimoto D, Okamoto Y, et al. Receptor-activated Smad localisation in bleomycin-induced pulmonary fibrosis[J ]. J Clin Pathol, 2007,60 (3) : 283 - 289
  • 7Cook DN. A matrix for new ideas in pulmonary fibrosis[J]. Am J Respir Cell Mol Boil, 2002,27 (2) : 122 - 124
  • 8Derynck R. Smad-dependent and Smad-independent pathways in TGFβ family signaling[J]. Nature,2003,425(6958):577-579
  • 9Gonzalez AV. Imbalance of receptor-regulated and inhibitory Smads in lung fibroblasts from bleomyein-exposed rats [ J ]. Am J Respir Cell Mol Biol,2007,36(2) :206-212
  • 10章巍,刘新民,李海潮,张红.博来霉素致大鼠肺纤维化模型肺组织MMP-2、MMP-9、MT1-MMP及TIMP-1、TIMP-2的表达[J].北京大学学报(医学版),2002,34(6):716-721. 被引量:25

共引文献634

同被引文献16

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部